4,6-Dichloro-2-Methylpyrimidine CAS 1780-26-3 Purity ≥99.5% (GC) Factory Hot Sale
Shanghai Ruifu Chemical Co., Ltd. is the leading manufacturer and supplier of 4,6-Dichloro-2-Methylpyrimidine (CAS: 1780-26-3) with high quality, commercial production. We can provide COA, worldwide delivery, small and bulk quantities available. Please contact: alvin@ruifuchem.com
Dzina la Chemical | 4,6-Dichloro-2-Methylpyrimidine |
Mawu ofanana ndi mawu | 2-Methyl-4,6-Dichloropyrimidine;2,4-Dichloro-6-Methylpyrimidine |
Nambala ya CAS | 1780-26-3 |
Nambala ya CAT | RF-PI687 |
Stock Status | Mu Stock, Kupanga Kukula Mpaka Matani |
Molecular Formula | C5H4Cl2N2 |
Kulemera kwa Maselo | 163.00 |
Melting Point | 41.5 ~ 45.5 ℃ (lit.) |
Kusungunuka (Kusungunuka mkati) | Methanol |
Mtundu | Ruifu Chemical |
Kanthu | Zofotokozera |
Maonekedwe | Ufa Woyera kapena Woyera wa Crystalline |
Kuyera / Kusanthula Njira | ≥99.5% (GC) |
Kutaya pa Kuyanika | ≤0.50% |
Zotsalira pa Ignition | ≤0.20% |
Chidetso Chimodzi | ≤0.50% |
Zonse Zonyansa | ≤0.50% |
Test Standard | Enterprise Standard |
Kugwiritsa ntchito | Mankhwala Wapakatikati;Dasatinib/Moxonidine Intermediate |
4,6-Dichloro-2-Methylpyrimidine (CAS: 1780-26-3) Njira Yopangira
Phukusi: Botolo, Aluminiyamu zojambulazo thumba, 25kg/Cardboard Drum, kapena malinga ndi lamulo la kasitomala
Mkhalidwe Wosungira:Sungani m'mitsuko yosindikizidwa pamalo ozizira ndi owuma;Tetezani ku kuwala ndi chinyezi
4,6-Dichloro-2-Methylpyrimidine (CAS: 1780-26-3) imagwiritsidwa ntchito popanga mankhwala apakatikati ndi ma API.Kukonzekera Zopangira: Moxonidine (CAS: 75438-57-2);Dasatinib (CAS: 302962-49-8);Dasatinib Monohydrate (CAS: 863127-77-9);4-Chloro-2,6-Dimethylpyrimidine (CAS: 4472-45-1);4-Amino-6-Chloro-2-Methylpyrimidine (CAS: 1749-68-4).Moxonidine ndi mtundu watsopano wa mankhwala antihypertensive, omwe amagwiritsidwa ntchito kwambiri pochiza matenda oopsa kwambiri.Poyerekeza ndi ma antihypertensive akale apakati, Moxonidine amamanga ndi kuyanjana kwakukulu kwa imidazoline I1-receptor kuposa α2-receptor.Dasatinib ndi oral oral oncogenic kinase inhibitor, yomwe imatha kuletsa kuwonjezereka kwa maselo a khansa, mu Meyi 2009, US Food and Drug Administration (FDA) idavomereza kugulitsa dasatinib, Yakhala ikugwiritsidwa ntchito pochiza matenda osiyanasiyana osachiritsika. myeloid leukemia (CML), kuphatikizapo chithandizo cha matenda a myeloid leukemia omwe ndi osagwirizana kapena osagwirizana ndi mapulogalamu ochizira kuphatikizapo imatinib mesylate., Philadelphia chromosome-positive acute lymphoblastic leukemia (Ph + ALL) komanso chithandizo cha odwala omwe ali ndi zotupa zolimba.